ReviewForensic science international. Synergy2026
Toward a European standard for elimination DNA databases: Policy recommendations for harmonized minimum requirements.
Review in Forensic science international. Synergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elimination DNA databases (EDBs) hold reference profiles from personnel who may inadvertently transfer DNA to evidentiary items (e.g., laboratory staff and crime-scene practitioners). When properly governed and audited, EDBs provide a critical quality assurance layer: they enable timely detection of contamination, prevent false investigative leads, and protect the integrity of cross-border database exchange. Yet practice across Europe remains heterogeneous. This narrative review synthesizes the scientific, legal, and quality assurance landscape for EDBs in European forensic DNA practice. We review variations in national approaches, examine interfaces with ISO/IEC 17025, analyze applicable EU data-protection law - arguing that EDBs structured as standing quality assurance systems fall under the GDPR - and consider cross-border implications under Prüm II. We also address proportional scope, retention, and the risks of scope creep or secondary use. Building on European Network of Forensic Science Institutes (ENFSI) guidance, accreditation practice, and empirical contamination studies, we propose policy recommendations for harmonized minimum requirements: laboratory information management system (LIMS)-enforced pre-submission EDB checks (before national database submissions and Prüm queries); strict organizational and technical separation from criminal/intelligence databases; role-based inclusion that extends beyond laboratory staff to high-risk scene and support roles; risk-proportionate retention with automatic deletion on exit; auditable incident response and management review; and transparency measures consistent with staff rights. We outline feasible legal and governance pathways (Prüm II practical guidance, updated professional standards, accreditation checklists, and - medium-term - EU-level legislation) and identify research priorities, including measuring EDB effectiveness, improving contamination-prevention practices across crime-scene and laboratory workflows, and developing privacy-preserving EDB architectures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.